NeuroSense receives Japanese patent for ALS drug candidate PrimeC
Go back to NeuroSense receives Japanese patent for ALS drug candidate PrimeC| (NASDAQ: NRSN) | Delayed: 0.45 +0.01 (2.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.44 | 52 Week High | $ | |||
| Open | $0.44 | 52 Week Low | $ | |||
| Day High | $0.46 | P/E | N/A | |||
| Day Low | $0.44 | EPS | $ | |||
| Volume | 55,517 | |||||
| (NASDAQ: NRSNW) | Delayed: 0.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.12 | 52 Week High | $ | |||
| Open | $0.12 | 52 Week Low | $ | |||
| Day High | $0.12 | P/E | N/A | |||
| Day Low | $0.12 | EPS | $ | |||
| Volume | 6 | |||||

